larazotide
Jump to navigation
Jump to search
Indications
- originally designed to treat celiac disease
- multisystem inflammatory syndrome in children (MIS-C)*
* safe & effective[1]
Mechanism of action
- zonulin antagonist
- clears spike protein in children with multisystem inflammatory syndrome (MIS-C)
More general terms
References
- ↑ 1.0 1.1 Yonker LM, Kane AS, Swank Z et al Viral spike antigen clearance and augmented recovery in children with post-COVID multisystem inflammatory syndrome treated with larazotide. Sci Transl Med. 2025 Jul 30;17(809):eadu4284. PMID: https://pubmed.ncbi.nlm.nih.gov/40737433